In the insulin resistant state, patients develop compensatory hyperinsulinemia but insulin’s vascular responses through the PI3-kinase/Akt/eNOS pathway are attenuated while its actions via the MAPK pathway remain intact or even enhanced (i.e., a pathway selective insulin resistance) [7,28,29]. This evidence concerns the gene INS and Insulin resistance.